SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21627359
Source:
http://linkedlifedata.com/resource/pubmed/id/21627359
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007137
,
umls-concept:C0017262
,
umls-concept:C0185117
,
umls-concept:C0456600
,
umls-concept:C0460004
,
umls-concept:C0525037
,
umls-concept:C0681842
,
umls-concept:C0871261
,
umls-concept:C1446409
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911684
,
umls-concept:C2911692
pubmed:issue
3
pubmed:dateCreated
2011-6-1
pubmed:abstractText
The objective of this study was to evaluate the effect of p16 expression on response to chemoradiation in stage IVa/b head and neck squamous cell carcinoma (HNSCC) patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101130625
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status
MEDLINE
pubmed:issn
1513-7368
pubmed:author
pubmed-author:ChenYi-JuYJ
,
pubmed-author:ChienChih-YenCY
,
pubmed-author:ChiuTai-JanTJ
,
pubmed-author:FangFu-MinFM
,
pubmed-author:HuangTai-LinTL
,
pubmed-author:RauKun-MingKM
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
649-55
pubmed:meshHeading
pubmed-meshheading:21627359-Adult
,
pubmed-meshheading:21627359-Aged
,
pubmed-meshheading:21627359-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:21627359-Brachytherapy
,
pubmed-meshheading:21627359-Carcinoma, Squamous Cell
,
pubmed-meshheading:21627359-Cisplatin
,
pubmed-meshheading:21627359-Cohort Studies
,
pubmed-meshheading:21627359-Combined Modality Therapy
,
pubmed-meshheading:21627359-Cyclin-Dependent Kinase Inhibitor p16
,
pubmed-meshheading:21627359-Female
,
pubmed-meshheading:21627359-Fluorouracil
,
pubmed-meshheading:21627359-Follow-Up Studies
,
pubmed-meshheading:21627359-Head and Neck Neoplasms
,
pubmed-meshheading:21627359-Humans
,
pubmed-meshheading:21627359-Immunoenzyme Techniques
,
pubmed-meshheading:21627359-Male
,
pubmed-meshheading:21627359-Middle Aged
,
pubmed-meshheading:21627359-Prognosis
,
pubmed-meshheading:21627359-Retrospective Studies
,
pubmed-meshheading:21627359-Survival Rate
,
pubmed-meshheading:21627359-Tumor Markers, Biological
pubmed:year
2011
pubmed:articleTitle
High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma.
pubmed:affiliation
Department of Pathology,Cancer Center, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan. taijanchiu@163.com
pubmed:publicationType
Journal Article